Scholarlink

<p>A role for the P2Y<sub>1</sub> receptor (P2Y<sub>1</sub>R) in platelet-driven inflammation has been established using a pharmacological approach, limited to an acute 4&#xa0;h time span. Nucleotide-structure P2Y<sub>1</sub>R antagonists have restricted experimental use due to inadequate pharmacokinetics, and an inability to decipher global versus cell specific effects in vivo. The creation of a conditional knock out (platelet) P2Y<sub>1</sub>R transgenic mouse model was designed to overcome these restrictions.</p><p>A homozygous P2Y<sub>1</sub> <i>LoxP</i> mouse colony was created using CRISPR/Cas9 technology, and crossed with a hemizygous P2Y<sub>1</sub> <i>LoxP</i> with PF4-cre to provide offspring that are homozygous for P2Y<sub>1</sub> <i>LoxP</i> flanked allele, and hemizygous for the PF4cre (platelet P2Y<sub>1</sub><sup>−/−</sup>) and offspring homozygous for P2Y<sub>1</sub> <i>LoxP</i> flanked allele, but non-carriers for PF4cre (control mice). Animals were intranasally administered LPS to induce pulmonary inflammation to assess the influence of phenotype on leukocyte recruitment.</p><p>24&#xa0;h post intranasal LPS administration; pulmonary neutrophil and platelet recruitment were significantly suppressed, despite the fact that neutrophils retained the ability to migrate to fMLP ex vivo. Circulating platelet and leukocyte numbers were not different between control and platelet P2Y<sub>1</sub><sup>−/−</sup> animals. Tail bleeding times revealed the platelet P2Y<sub>1</sub><sup>−/−</sup> mice had a severe bleeding phenotype.</p><p>The platelet specific P2Y<sub>1</sub><sup>−/−</sup> mouse model confirms the importance of platelet P2Y<sub>1</sub>R in the regulation of inflammatory responses. A 60–70% inhibition of leukocyte recruitment over an extended time period was observed compared to previous pharmacological studies. Platelet P2Y<sub>1</sub><sup>−/−</sup> mice will help further elucidate the mechanisms by which P2Y<sub>1</sub>R regulate platelet activation during inflammation.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Platelet-specific P2Y1 receptor deficient mice have suppressed pulmonary leukocyte recruitment in response to lipopolysaccharide

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月5日

查看全文
  • Dingxin Pan,
  • Alembert Lino-Alvarado,
  • Richard T. Amison,
  • Tolga Oralman,
  • Reah Evans,
  • Oliver Baker,
  • Graham Cocks,
  • Clive P. Page,
  • Simon C. Pitchford

摘要

A role for the P2Y1 receptor (P2Y1R) in platelet-driven inflammation has been established using a pharmacological approach, limited to an acute 4 h time span. Nucleotide-structure P2Y1R antagonists have restricted experimental use due to inadequate pharmacokinetics, and an inability to decipher global versus cell specific effects in vivo. The creation of a conditional knock out (platelet) P2Y1R transgenic mouse model was designed to overcome these restrictions.

A homozygous P2Y1 LoxP mouse colony was created using CRISPR/Cas9 technology, and crossed with a hemizygous P2Y1 LoxP with PF4-cre to provide offspring that are homozygous for P2Y1 LoxP flanked allele, and hemizygous for the PF4cre (platelet P2Y1−/−) and offspring homozygous for P2Y1 LoxP flanked allele, but non-carriers for PF4cre (control mice). Animals were intranasally administered LPS to induce pulmonary inflammation to assess the influence of phenotype on leukocyte recruitment.

24 h post intranasal LPS administration; pulmonary neutrophil and platelet recruitment were significantly suppressed, despite the fact that neutrophils retained the ability to migrate to fMLP ex vivo. Circulating platelet and leukocyte numbers were not different between control and platelet P2Y1−/− animals. Tail bleeding times revealed the platelet P2Y1−/− mice had a severe bleeding phenotype.

The platelet specific P2Y1−/− mouse model confirms the importance of platelet P2Y1R in the regulation of inflammatory responses. A 60–70% inhibition of leukocyte recruitment over an extended time period was observed compared to previous pharmacological studies. Platelet P2Y1−/− mice will help further elucidate the mechanisms by which P2Y1R regulate platelet activation during inflammation.

Graphical Abstract